
|Videos|June 23, 2021
Dr. Ramasamy discusses clinical trial of nasal testosterone gel
Author(s)Urology Times staff
“It's quick to act and it's quick to leave the system,” says Ranjith Ramasamy, MD, of the nasal testosterone gel Natesto.
Advertisement
In this video, Ranjith Ramasamy, MD, discusses a clinical trial at his institution evaluating the nasal testosterone gel Nastesto. Ramasamy is an associate professor of urology and director of male reproductive medicine and surgery at the University of Miami Miller School of Medicine.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Study suggests tamsulosin deprescribing may be appropriate for select men with BPH
2
FDA greenlights phase 1 study of UGN-501 for NMIBC
3
Trial launches of actinium (225Ac) rhPSMA-10.1 injection in mCRPC
4
Urocross shows sustained benefit through 24 months post-removal
5












